LD (LEIGHS DISEASE)DETECTION / EDTA BLOOD

image not found

NABL Cap Accredited     
LD (Leigh’s Disease) Detection / EDTA Blood is a genetic or molecular test used to identify mutations associated with Leigh’s Disease, a rare inherited neurometabolic disorder affecting the central nervous system. The test helps in early diagnosis, carrier detection, and genetic counseling. Metropolis Healthcare performs this test using advanced PCR and molecular techniques to ensure accurate detection of disease-related genetic variants

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 15,225.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: L0009

Frequently Asked Questions (FAQ's):

What does this test detect?
It identifies genetic mutations linked to Leigh’s Disease to support early diagnosis and management.

Who should undergo this test?
Individuals with neurological symptoms, developmental delays, or a family history of Leigh’s Disease.

Is fasting required?
No fasting is required.

What type of sample is needed?
An EDTA blood sample is collected for molecular analysis.

How does Metropolis Healthcare perform this test?
Using PCR and advanced genetic testing methods to detect disease-associated mutations.

Can this test be used for carrier screening?
Yes, it is useful for carrier detection and family planning guidance.

Are additional tests recommended?
Metropolis Healthcare may advise mitochondrial function tests or further genetic counseling for comprehensive assessment

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab